Iron deficiency in sports - Definition, influence on performance and therapy: Consensus statement of the Swiss Society of Sports Medicine

Swiss Medical Weekly

Volumn 145, Issue , 2015, Pages

  Clénin, German E ^a   Cordes, Mareike ^a   Huber, Andreas ^b   Schumacher, Yorck Olaf ^c   Noack, Patrick ^d   Scales, John ^e   Kriemler, Susi ^f  

^a Haus des Sports   (Switzerland)

^b CANTONAL HOSPITAL AARAU   (Switzerland)

^c ASPETAR ORTHOPAEDIC AND SPORTS MEDICINE HOSPITAL   (Qatar)

^d Zentrum für Medizin und Sport Im Säntispark   (Switzerland)

^e Bannockburn Hospital   (United Kingdom)

^f UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Diagnosis of iron deficiency; Dilutional pseudoanaemia in sports; Ferritin cut off; Iron deficiency and performance; Iron deficiency in sports; Treatment of iron deficiency

Indexed keywords

FERRIC CARBOXYMALTOSE; FERRITIN; HEMOGLOBIN; IRON; IRON SACCHARATE; IRON INTAKE;

ADOLESCENT; ATHLETE; CHILD; HEMATOCRIT; HUMAN; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON INTAKE; IRON METABOLISM; IRON STORAGE; IRON THERAPY; IRON TRANSPORT; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MICROCYTOSIS; NUTRITIONAL COUNSELING; PHYSICAL PERFORMANCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPORT; ADULT; ANEMIA, IRON-DEFICIENCY; ATHLETIC PERFORMANCE; BLOOD; DIETARY SUPPLEMENT; FEMALE; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; THERAPEUTIC USE; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA, IRON-DEFICIENCY; ATHLETES; ATHLETIC PERFORMANCE; CHILD; DIETARY SUPPLEMENTS; FEMALE; FERRITINS; HEMATOCRIT; HEMOGLOBINS; HUMANS; IRON; IRON, DIETARY; MALE; YOUNG ADULT;

EID: 84982867212     PISSN: 14247860     EISSN: 14243997     Source Type: Journal    
DOI: 10.4414/smw.2015.14196     Document Type: Review

References (127)

1. Proposed nutrient and energy intakes for the European community: a report of the Scientific Committee for Food of the European community. Nutr Rev. 1993;51:209-12.
2. Egli I. M. MARIA ANDERSSON&z.ast;, INES M. EGLI&z.ast;, MICHAEL B. ZIMMERMANN. at 'http://www.rosenfluh.ch/rosenfluh/articles/download/1318/Eisenmangel.pdf'
3. Schleiffenbaum BE, et al. Unexpected high prevalence of metabolic disorders and chronic disease among young male draftees - the Swiss Army XXI experience. Swiss Med Wkly. 2006;136:175-84.
4. Sandström G, Börjesson M, Rödjer S. Iron deficiency in adolescent female athletes - is iron status affected by regular sporting activity? Clin J Sport Med. 2012;22:495-500.
5. Latunde-Dada G. O. Iron metabolism in athletes- achieving a gold standard. Eur J Haematol. (2012). doi:10.1111/ejh.12026
6. Dubnov G, et al. High prevalence of iron deficiency and anemia in female military recruits. Mil Med. 2006;171:866-9.
7. Cippa P, Krayenbühl P-A. Eisenmangel: Es geht nicht nur um Anämie. Schweiz Med Forum. 2014;11-12.
8. Martius F. Eisenmangel ohne Anämie - ein heisses Eisen. in Schweiz Med Forum. 2009;9:294-9.
9. Streuli R. A. Ferrum bonum et laudabile (lucrosumque). in Schweiz Med Forum. 2008;8:563.
10. Colombani PC, Mannhart C. Energie- und Nährstoffaufnahme im Schweizer Spitzensport - eine erste Bestandsaufnahme zu Beginn des zweiten Jahrtausends. 2003;7-16.
11. Mettler S, Zimmermann M. B. Iron excess in recreational marathon runners. Eur J Clin Nutr. 2010;64490-4.
12. Ganz T. Molecular Control of Iron Transport. JASN. 2007;18:394-400.
13. Löffler G. in S.416 ff (Springer Verlag).
14. Ganz T, Nemeth E. Iron metabolism: interactions with normal and disordered erythropoiesis. Cold Spring Harb Perspect Med. 2012;2:a011668.
15. Yip R. in Present Knowledge in Nutrition, Bowman BA, Russell RM 311-328 (ILSI Press, Washington DC, 2001).
16. Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr. 2006;26:323-42.
17. Young B, Zaritsky J. Hepcidin for clinicians. Clin J Am Soc Nephrol. 2009;4:1384-7.
18. Taylor C, et al. Hematologic, iron-related, and acute-phase protein responses to sustained strenuous exercise. J Appl Physiol. 1987;62:464-9.
19. Peeling P, Dawson B, Goodman C, Landers G, Trinder D. Athletic induced iron deficiency: new insights into the role of inflammation, cytokines and hormones. Eur J Appl Physiol. 2008;103:381-91.
20. Peeling P. Exercise as a mediator of hepcidin activity in athletes. Eur J Appl Physiol. 2010;110:877-83.
21. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102:783-8.
22. Newlin MK, et al. The effects of acute exercise bouts on hepcidin in women. Int J Sport Nutr Exerc Metab. 2012;22:79-88.
23. Gaudin C, Zerath E, Guezennec CY. Gastric lesions secondary to long-distance running. Dig Dis Sci. 1990;35:1239-43.
24. Peters HP, De Vries WR, Vanberge-Henegouwen GP, Akkermans LM. Potential benefits and hazards of physical activity and exercise on the gastrointestinal tract. Gut. 2001;48:435-9.
25. Waller MF, Haymes EM. The effects of heat and exercise on sweat iron loss. Med Sci Sports Exerc. 1996;28:197-203.
26. Jones GR, Newhouse I. Sport-related hematuria: a review. Clin J Sport Med. 1997;7:119-25.
27. Miller BJ, Pate RR, Burgess W. Foot impact force and intravascular hemolysis during distance running. Int J Sports Med. 1988;9:56-60.
28. Telford RD, et al. Footstrike is the major cause of hemolysis during running. J Appl Physiol. 2003;94:38-42.
29. Herklotz R, Huber A. Labordiagnose von Eisenstoffwechselstörungen. in Schweiz Med Forum. 2010;10:500-7.
30. Brugnara C, Laufer MR, Friedman AJ, Bridges K, Platt O. Reticulocyte hemoglobin content (CHr): early indicator of iron deficiency and response to therapy. Blood. 1994;83:3100-1.
31. Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem. 2002;48:1066-76.
32. Macdougall IC. What is the most appropriate strategy to monitor functional iron deficiency in the dialysed patient on rhEPO therapy? Merits of percentage hypochromic red cells as a marker of functional iron deficiency. Nephrol Dial Transplant. 1998;13:847-9.
33. Onofrio G d', Zini G, Ricerca BM, Mancini S, Mango G. Automated measurement of red blood cell microcytosis and hypochromia in iron deficiency and beta-thalassemia trait. Arch Pathol Lab Med. 1992;116:84-9.
34. Onofrio G d', et al. Simultaneous measurement of reticulocyte and red blood cell indices in healthy subjects and patients with microcytic and macrocytic anemia. Blood. 1995;85:818-23.
35. Brugnara C, Zurakowski D, DiCanzio J, Boyd T, Platt O. Reticulocyte hemoglobin content to diagnose iron deficiency in children. JAMA. 1999;281:2225-30.
36. Franck S, Linssen J, Messinger M., Thomas L. Potential utility of Ret-Y in the diagnosis of iron-restricted erythropoiesis. Clin Chem. 2004;50:1240-2.
37. Schumacher YO, Schmid A, König D, Berg A. Effects of exercise on soluble transferrin receptor and other variables of the iron status. Br J Sports Med. 2002;36:195-9.
38. Magge H, Sprinz P, Adams WG, Drainoni M-L, Meyers A. Zinc protoporphyrin and iron deficiency screening: trends and therapeutic response in an urban pediatric center. JAMA Pediatr. 2013;167:361-7.
39. Baart AM, et al. High prevalence of subclinical iron deficiency in whole blood donors not deferred for low hemoglobin. Transfusion. 2013;53:1670-7.
40. Voss SC, et al. Variability of serum markers of erythropoiesis during 6 days of racing in highly trained cyclists. Int J Sports Med. 2014;35:89-94.
41. Cordova A, Monserrat J, Villa G, Reyes E, Soto MA-M. Effects of AM3 (Inmunoferon) on increased serum concentrations of interleukin-6 and tumour necrosis factor receptors I and II in cyclists. J Sports Sci. 2006;24:565-73.
42. Dickson DN, Wilkinson RL, Noakes TD. Effects of ultra-marathon training and racing on hematologic parameters and serum ferritin levels in well-trained athletes. Int J Sports Med. 1982;3:111-7.
43. Fallon KE, Sivyer G, Sivyer K, Dare A. The biochemistry of runners in a 1600 km ultramarathon. Br J Sports Med. 1999;33:264-9.
44. Friedmann B. Standards der Sportmedizin Sportleranämie. DEUTSCHE ZEITSCHRIFT FÜR SPORTMEDIZIN 2001;52.
45. Shaskey DJ, Green GA. Sports haematology. Sports Med. 2000;29:27-38.
46. Bärtsch P, Mairbäurl H, Friedmann B. Pseudo-anemia caused by sports. Ther Umsch. 1998;55:251-5.
47. Nichols AW. Nonorthopaedic problems in the aquatic athlete. Clin Sports Med. 1999;18:395-411, viii.
48. Heinicke K, et al. Blood volume and hemoglobin mass in elite athletes of different disciplines. Int J Sports Med. 2001;22:504-12.
49. Steiner T, Wehrlin JP. Does hemoglobin mass increase from age 16 to 21 and 28 in elite endurance athletes? Med Sci Sports Exerc. 2011;43:1735-43.
50. Steiner T, Wehrlin JP. Comparability of haemoglobin mass measured with different carbon monoxide-based rebreathing procedures and calculations. Scand J Clin Lab Invest. 2011;71:19-29.
51. Hinrichs T, et al. Total hemoglobin mass, iron status, and endurance capacity in elite field hockey players. J Strength Cond Res. 2010;24:629-38.
52. Wehrlin JP. Live high-train low for 24 days increases hemoglobin mass and red cell volume in elite endurance athletes. J Appl Physiol. 2006;100:1938-45.
53. Garvican LA, et al. Intravenous Iron Supplementation in Distance Runners with Low or Suboptimal Ferritin. Med Sci Sports Exerc. (2013). doi:10.1249/MSS.0b013e3182a53594.
54. Fellmann N. Hormonal and plasma volume alterations following endurance exercise. A brief review. Sports Med. 1992;13:37-49.
55. Hamilton T, et al. Die Radsport-Mafia und ihre schmutzigen Geschäfte: Der Insider-bericht über die Welt des Profiradsports: eine minutiöse Beichte, die erstmals das ganze ... Armstrongs Schlüsselrolle darin aufzeigt. (2012).
56. 40-ans.pdf. at 'http://oldsite.uci.ch/english/health-sante/docs/40-ans.pdf'
57. Bad blood: Nature News. at 'http://www.nature.com//news/2006/060224/full/news060220-18.html'
58. Athlete Biological Passport (ABP) Operating Guidelines | World Anti-Doping Agency. at 'https://www.wada-ama.org/en/resources/athlete-biological-passport/athlete-biological-passport-abp-operating-guidelines'
59. Saugy M, Lundby C, Robinson N. Monitoring of biological markers indicative of doping: the athlete biological passport. Br J Sports Med. 2014;48:827-32.
60. Davies KJ, Maguire JJ, Brooks GA, Dallman PR, Packer L. Muscle mitochondrial bioenergetics, oxygen supply, and work capacity during dietary iron deficiency and repletion. Am J Physiol. 1982;242:E418-427.
61. Davies KJ, et al. Distinguishing effects of anemia and muscle iron deficiency on exercise bioenergetics in the rat. Am J Physiol. 1984;246:E535-543.
62. Finch CA, et al. Iron deficiency in the rat. Physiological and biochemical studies of muscle dysfunction. J Clin Invest. 1976;58:447-53.
63. Burden RJ, et al. Impact of Intravenous Iron on Aerobic Capacity and Iron Metabolism in Elite Athletes. Med Sci Sports Exerc. (2014). doi:10.1249/MSS.0000000000000568
64. Garvican LA, et al. Intravenous iron supplementation in distance runners with low or suboptimal ferritin. Med Sci Sports Exerc. 2014;46:376-85.
65. DellaValle DM, Haas JD. Iron supplementation improves energetic efficiency in iron-depleted female rowers. Med Sci Sports Exerc. 2014;46:1204-15.
66. Waldvogel S, et al. Clinical evaluation of iron treatment efficiency among non-anemic but iron-deficient female blood donors: a randomized controlled trial. BMC Med. 2012;10;8.
67. McClung JP, et al. Randomized, double-blind, placebo-controlled trial of iron supplementation in female soldiers during military training: effects on iron status, physical performance, and mood. Am J Clin Nutr. 2009;90:124-31.
68. Hinton PS, Sinclair LM. Iron supplementation maintains ventilatory threshold and improves energetic efficiency in iron-deficient nonanemic athletes. Eur J Clin Nutr. 2007;61:30-9.
69. Brownlie T, 4th, Utermohlen V, Hinton PS, Haas JD. Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. Am J Clin Nutr. 2004;79:437-43.
70. Brownlie T, 4th, Utermohlen V, Hinton PS, Giordano C, Haas JD. Marginal iron deficiency without anemia impairs aerobic adaptation among previously untrained women. Am J Clin Nutr. 2002;75:734-42.
71. Friedmann B, Weller E, Mairbaurl H, Bärtsch P. Effects of iron repletion on blood volume and performance capacity in young athletes. Med Sci Sports Exerc. 2001;33:741-6.
72. Hinton PS, Giordano C, Brownlie T, Haas J. D. Iron supplementation improves endurance after training in iron-depleted, nonanemic women. J Appl Physiol. 2000;88:1103-11.
73. WHO. WHO | Iron deficiency anaemia: assessment, prevention and control. WHO at 'http://www.who.int/nutrition/publications/micronutrients/anaemia-iron-deficiency/WHO-NHD-01.3/en/'
74. Hallberg L, et al. Screening for iron deficiency: an analysis based on bone-marrow examinations and serum ferritin determinations in a population sample of women. Br J Haematol. 1993;85:787-98.
75. van Tellingen O. The importance of drug-transporting P-glycoproteins in toxicology. Toxicol Lett. 2001;120:31-41.
76. Magnusson B, Hallberg L, Rossander L, Swolin B. Iron metabolism and 'sports anemia'. I. A study of several iron parameters in elite runners with differences in iron status. Acta Med Scand. 1984,216:149-55.
77. Thomason RW, Almiski MS. Evidence that stainable bone marrow iron following parenteral iron therapy does not correlate with serum iron studies and may not represent readily available storage iron. Am J Clin Pathol. 2009;131:580-5.
78. Krayenbuehl P-A, Battegay E, Breymann C, Furrer J, Schulthess G. Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood. 2011;118:3222-7.
79. Verdon F, et al. Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. BMJ. 2003;326:1124.
80. Vaucher P, Druais P-L, Waldvogel S, Favrat B. Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial. CMAJ. 2012;184:1247-54.
81. Gropper SS, Bader-Crowe DM, McAnulty LS, White BD, Keith RE. Non-anemic iron depletion, oral iron supplementation and indices of copper status in college-aged females. J Am Coll Nutr. 2002;21:545-52.
82. Brutsaert TD, et al. Iron supplementation improves progressive fatigue resistance during dynamic knee extensor exercise in iron-depleted, non-anemic women. Am J Clin Nutr. 2003;77:441-8.
83. Clénin GE. Eisen im Sport - oft zu wenig, gelegentlich aber auch zu viel! Schweizerische Zeitschrift für Ernährungsmedizin. 2006;21-25.
84. Mettler S. Ferrum - ein Mineralstoff im Sport. SCHWEIZERISCHE ZEITSCHRIFT FUR SPORTMEDIZIN UND SPORTTRAUMATOLOGIE 2004;52:105-14.
85. Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem. 1998;44:45-51.
86. Lamanca JJ, Haymes EM. Effects of low ferritin concentration on endurance performance. Int J Sport Nutr. 1992;2:376-85.
87. Yu D, Huo J, Xie L, Wang L. Meta-analysis of studies on cut-off value of serum ferritin for identifying iron deficiency. Wei Sheng Yan Jiu. 2013;42:228-35.
88. Pitsis GC, Fallon KE, Fallon SK, Fazakerley R. Response of soluble transferrin receptor and iron-related parameters to iron supplementation in elite, iron-depleted, nonanemic female athletes. Clin J Sport Med. 2004;14:300-4.
89. Fallon KE. Screening for haematological and iron-related abnormalities in elite athletes-analysis of 576 cases. J Sci Med Sport. 2008;11:329-36.
90. Fallon KE. Utility of hematological and iron-related screening in elite athletes. Clin J Sport Med. 2004;14:145-52.
91. Bothwell TH, Charlton RW, Cook JD, Finch CA. IRon metabolism in man. Oxford, UK: Blackwell Scientific Publications (1979).
92. Miret S, Simpson RJ, McKie AT. Physiology and molecular biology of dietary iron absorption. Annu Rev Nutr. 2003;23:283-301.
93. Zimmermann MB, Biebinger R, Egli I, Zeder C, Hurrell RF. Iron deficiency up-regulates iron absorption from ferrous sulphate but not ferric pyrophosphate and consequently food fortification with ferrous sulphate has relatively greater efficacy in iron-deficient individuals. Br J Nutr. 2011;105:1245-50.
94. Monsen ER. Iron nutrition and absorption: dietary factors which impact iron bioavailability. J Am Diet Assoc. 1988;88:786-90).
95. Hercberg S, Preziosi P, Galan P. Iron deficiency in Europe. Public Health Nutr. 2001;4:537-45.
96. Rimon E, et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med. 2005;118:1142-7.
97. Zimmermann M.B, et al. Plasma hepcidin is a modest predictor of dietary iron bioavailability in humans, whereas oral iron loading, measured by stable-isotope appearance curves, increases plasma hepcidin. Am J Clin Nutr. 2009;90:1280-7.
98. DellaValle DM. Iron supplementation for female athletes: effects on iron status and performance outcomes. Curr Sports Med Rep. 2013;12:234-9.
99. Cancelo-Hidalgo MJ, et al. Tolerability of different oral iron supplements: a systematic review. Curr Med Res Opin. 2013;29:291-303.
100. Arzneimittel-Kompendium der Schweiz. (Documed, 2012).
101. Ritzmann, P. Eisencarboxymaltose. pharma-kritik 2010;32:29-31.
102. Rienso®, Lösung zur intravenösen Injektion (Ferumoxytol) - Swiss-medic -. at 'https://www.swissmedic.ch/zulassungen/00153/00189/00200/00497/index.html?lang=de'
103. Rienso, Lösung zur intravenösen Injektion - Swissmedic -. at 'https://www.swissmedic.ch/marktueberwachung/00135/00166/00707/index.html?lang=de'
104. Arzneimittelinformation. at 'http://www.swissmedicinfo.ch/'
105. Arzneimittelinformation. at 'http://www.swissmedicinfo.ch/'
106. Prohibited List. World Anti-Doping Agency at 'http://www.wada-ama.org/en/World-Anti-Doping-Program/Sports-and-Anti-Doping-Organizations/International-Standards/Prohibited-List/'
107. Demarmels Biasiutti F. Die Regulation des Eisenstoffwechsels. Schweiz Med Forum. 2009;630-2.
108. Koskenkorva-Frank TS, Weiss G, Koppenol WH, Burckhardt S. The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress. Free Radic Biol Med. 2013;65:1174-94.
109. Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J. Body iron metabolism and pathophysiology of iron overload. Int J Hematol. 2008;88:7-15.
110. Steinboeck F, et al. The relevance of oxidative stress and cytotoxic DNA lesions for spontaneous mutagenesis in non-replicating yeast cells. Mutat Res. 2010;688:47-52.
111. Nowsheen S, et al. Accumulation of oxidatively induced clustered DNA lesions in human tumor tissues. Mutat Res. 2009;674:131-6.
112. Pingitore A, et al. Exercise and oxidative stress: Potential effects of antioxidant dietary strategies in sports. Nutrition. 2015;31:916-22.
113. Powers SK, Nelson WB, Hudson MB. Exercise-induced oxidative stress in humans: cause and consequences. Free Radic Biol Med. 2011;51:942-50.
114. Chua ACG, et al. Dietary iron enhances colonic inflammation and IL-6/IL-11-Stat3 signaling promoting colonic tumor development in mice. PLoS ONE. 2013;8:e78850.
115. Wurzelmann JI, Silver A, Schreinemachers DM, Sandler RS, Everson RB. Iron intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 1996;5:503-7.
116. Fonseca-Nunes A, Jakszyn P, Agudo A. Iron and cancer risk - a systematic review and meta-analysis of the epidemiological evidence. Cancer Epidemiol Biomarkers Prev. 2014;23:12-31.
117. Heath A-LM, Fairweather-Tait SJ. Clinical implications of changes in the modern diet: iron intake, absorption and status. Best Pract Res Clin Haematol. 2002;15:225-41.
118. Rossander-Hulthen L, Hallberg L. in Iron Nutrition in Health and Disease (Hallberg L.&Asp N.G.) 149-156 (John Libbey&Co; London, UK, 1996).
119. Constantini NW, Eliakim A, Zigel L, Yaaron M, Falk B. Iron status of highly active adolescents: evidence of depleted iron stores in gymnasts. Int J Sport Nutr Exerc Metab. 2000;10:62-70.
120. Rowland TW. Iron deficiency in the young athlete. Pediatr Clin North Am. 1990;37:1153-63.
121. Spodaryk K. Iron metabolism in boys involved in intensive physical training. Physiol Behav. 2002;75:201-6.
122. Fairweather-Tait S. in Iron Nutrition in Health and Disease (Hallberg L.&Asp N.G.) 137-148 (John Libbey&Co; London, UK, 1996).
123. Beard JL. Iron requirements in adolescent females. J Nutr. 2000;130:440S-442S.
124. Hallberg L. in Iron Nutrition in Health and Disease (Hallberg L.&Asp N.G.) 165-182 (John Libbey&Co; London, UK).
125. Raunikar RA, Sabio H. Anemia in the adolescent athlete. Am J Dis Child. 1992;146:1201-5.
126. Herklotz R, Lüthi I, Ottiger C, Huber AR. Referenzbereiche in der Hämatologie. Ther UmscH. 2006;63:5-24.
127. Dietary Reference Intakes (DRIs): Estimated Average Requirements for Groups - 5-Summary Table Tables 1-4.pdf. at http://www.iom.edu/Activities/Nutrition/SummaryDRIs/~/media/Files/Activity%20Files/Nutrition/DRIs/5-Summary%20Table%20Tables%201-4.pdf